Page last updated: 2024-11-02

pirenzepine and Hematologic Diseases

pirenzepine has been researched along with Hematologic Diseases in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cadario, B1

Other Studies

1 other study available for pirenzepine and Hematologic Diseases

ArticleYear
Olanzapine (Zyprexa): suspected serious reactions.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Jul-11, Volume: 163, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines

2000